Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
16.4M
-
Shares change
-
-311K
-
Total reported value, excl. options
-
$61.7M
-
Value change
-
-$15.2M
-
Put/Call ratio
-
0.12
-
Number of buys
-
43
-
Number of sells
-
-21
-
Price
-
$3.77
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q1 2022
71 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q1 2022.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.4M shares
of 148M outstanding shares and own 11.03% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.97M shares), ORBIMED ADVISORS LLC (3.66M shares), WELLINGTON MANAGEMENT GROUP LLP (1.78M shares), BlackRock Inc. (922K shares), FRANKLIN RESOURCES INC (420K shares), BANK OF AMERICA CORP /DE/ (419K shares), CITADEL ADVISORS LLC (413K shares), VANGUARD GROUP INC (405K shares), Pekin Hardy Strauss, Inc. (361K shares), and DAFNA Capital Management LLC (324K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.